Print Issue: October 01, 2011

Treating SLE in ESRD May Boost Survival

Frequent follow-up with a rheumatologist and continued immunosuppressive treatment for systemic lupus erythematosus (SLE) in patients with end-stage renal disease (ESRD) improves their chances of survival, according to a study.

Next post in Cardiovascular Disease (CVD)